Education, Science, Technology, Innovation and Life
Open Access
Sign In

Clinical Traditional Chinese Medicine Research in Hospitals and Its Clinical Value Analysis

Download as PDF

DOI: 10.23977/medsc.2024.050302 | Downloads: 6 | Views: 224

Author(s)

Qikang Zhao 1, Mengya Liu 2, Yue Zhang 1

Affiliation(s)

1 Chinese Materia Medica, Changchun Sci-Tech University, Changchun, Jilin, 130000, China
2 Nursing, Shijiazhuang Vocational College of Finance and Economics, Shijiazhuang, Hebei, 050000, China

Corresponding Author

Qikang Zhao

ABSTRACT

Clinical Chinese medicine, as an important component of traditional Chinese medicine, has played an increasingly important role in disease treatment, prevention, and rehabilitation in recent years. This article explores the current research status of clinical Chinese medicine in hospitals and its value in clinical practice. This article proposes a traditional Chinese medicine efficacy evaluation algorithm and a clinical value analysis model by reviewing relevant literature and analyzing clinical data, and conducts empirical testing and effectiveness analysis. The results indicate that these methods and models have certain practicality and effectiveness in traditional Chinese medicine research and clinical applications. The highest accuracy of this model can reach 91%, and the lowest is 82%. It can be seen that the accuracy fluctuates between 83% and 91%. The accuracy of most tests is concentrated around 85%, with only a few tests having accuracy lower or higher than this value. Overall, the accuracy remains at a high level with no significant downward trend. These data indicate that the system studied in this article has shown very high accuracy in testing, with an average accuracy rate much higher than 80%. 

KEYWORDS

Hospital Clinical, Traditional Chinese Medicine, Clinical Value, Research Analysis

CITE THIS PAPER

Qikang Zhao, Mengya Liu, Yue Zhang, Clinical Traditional Chinese Medicine Research in Hospitals and Its Clinical Value Analysis. MEDS Clinical Medicine (2024) Vol. 5: 7-14. DOI: http://dx.doi.org/10.23977/medsc.2024.050302.

REFERENCES

[1] Rech M A, Jones G M, Naseman R W, et al. Premature attrition of clinical pharmacists: call to attention, action, and potential solutions. Journal of the American College of Clinical Pharmacy, 2022, 5(7): 689-696.
[2] De With M, Knikman J, de Man F M, et al. Dihydropyrimidine dehydrogenase phenoty using pretreatment uracil: a note of caution based on a large prospective clinical study. Clinical Pharmacology & Therapeutics, 2022, 112(1): 62-68.
[3] Trakulsunti Y, Antony J, Edgeman R, et al. Reducing pharmacy medication errors using Lean Six Sigma: A Thai hospital case study. Total Quality Management & Business Excellence, 2022, 33(5-6): 664-682.
[4] Shubow S, Sun Q, Nguyen Phan A L, et al. Prescriber perspectives on biosimilar adoption and potential role of clinical pharmacology: a workshop summary. Clinical Pharmacology & Therapeutics, 2023, 113(1): 37-49.
[5] Le L M, Veettil S K, Donaldson D, et al. The impact of pharmacist involvement on immunization uptake and other outcomes: An updated systematic review and meta-analysis. Journal of the American Pharmacists Association, 2022, 62(5): 1499-1513. e16.
[6] Cooper‐DeHoff R M, Niemi M, Ramsey L B, et al. The clinical pharmacogenetics implementation consortium guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and statin‐associated musculoskeletal symptoms. Clinical Pharmacology & Therapeutics, 2022, 111(5): 1007-1021.
[7] Huang X, Estau D, Liu X, et al. Evaluating the performance of ChatGPT in clinical pharmacy: a comparative study of ChatGPT and clinical pharmacists. British journal of clinical pharmacology, 2024, 90(1): 232-238.
[8] Sandaradura I, Alffenaar J W, Cotta M O, et al. Emerging therapeutic drug monitoring of anti‐infective agents in Australian hospitals: availability, performance and barriers to implementation. British Journal of Clinical Pharmacology, 2022, 88(2): 669-679.
[9] van der Lee M, Swen J J. Artificial intelligence in pharmacology research and practice. Clinical and Translational Science, 2023, 16(1): 31-36.
[10] Reckweg J T, Uthaug M V, Szabo A, et al. The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N, N‐dimethyltryptamine (5‐MeO‐DMT). Journal of Neurochemistry, 2022, 162(1): 128-146.
[11] Li J, Wang X, Liu J, et al. Comparison of ciprofol (HSK3486) versus propofol for the induction of deep sedation during gastroscopy and colonoscopy procedures: A multi‐centre, non‐inferiority, randomized, controlled phase 3 clinical trial. Basic & Clinical Pharmacology & Toxicology, 2022, 131(2): 138-148.
[12] Nelson J, Alvey N, Bowman L, et al. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2022, 42(8): 599-633.
[13] Dagenais S, Russo L, Madsen A, et al. Use of real‐world evidence to drive drug development strategy and inform clinical trial design. Clinical Pharmacology & Therapeutics, 2022, 111(1): 77-89.
[14] Arrieta-Loitegui M, Caro-Teller J M, Ortiz-Pérez S, et al. Effectiveness, safety and cost analysis of dalbavancin in clinical practice. European Journal of Hospital Pharmacy, 2022, 29(1): 55-58.
[15] Harris M, Erridge S, Ergisi M, et al. UK Medical Cannabis registry: an analysis of clinical outcomes of medicinal cannabis therapy for chronic pain conditions. Expert review of clinical pharmacology, 2022, 15(4): 473-485.
[16] Selker H P, Cohen T, D’Agostino R B, et al. A Useful and Sustainable Role for N‐of‐1 Trials in the Healthcare Ecosystem. Clinical Pharmacology & Therapeutics, 2022, 112(2): 224-232.
[17] Ibrahim O M, Ibrahim R M, Ibrahim Y A, et al. Shedding the light on Pharmacists' roles during COVID-19 global pandemic. Saudi Pharmaceutical Journal, 2022, 30(1): 14-27.
[18] Jaam M, Awaisu A, El-Awaisi A, et al. Use of the Delphi technique in pharmacy practice research. Research in Social and Administrative Pharmacy, 2022, 18(1): 2237-2248.
[19] Al-Babtain B, Cheema E, Hadi M A. Impact of community-pharmacist-led medication review programmes on patient outcomes: A systematic review and meta-analysis of randomised controlled trials. Research in Social and Administrative Pharmacy, 2022, 18(4): 2559-2568.
[20] El-Dalati S, Cronin D, Riddell IV J, et al. The clinical impact of implementation of a multidisciplinary endocarditis team. The Annals of thoracic surgery, 2022, 113(1): 118-124. 

Downloads: 5116
Visits: 236041

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.